CDAKQ — Codiak BioSciences,. Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.06m
- -$26.01m
- $22.94m
Codiak BioSciences, Inc. reports results for the quarter ended in June - Earnings Summary
Brief: Codiak Biosciences Announces The Transition Of Benny Sorensen, M.D., Ph.D. To Scientific Advisory Board Member And Clinical Consultant Roles
Brief: Codiak BioSciences Appoints Anne-Virginie Eggimann to Board of Directors
Codiak BioSciences, Inc. reports results for the quarter ended in March - Earnings Summary
Brief: Codiak Biosciences Reports First Quarter 2021 Financial Results And Operational Progress
NASDAQ RESUMED AT 01:51 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:46 PM
Brief: Codiak Biosciences Says Co, Jazz Pharmaceuticals Ireland Agreed To Discontinue Work On Exoaso™-Stat3
U.S. RESEARCH ROUNDUP-Cactus, NRG Energy, Translate Bio
Brief: Codiak Biosciences Says Total Revenues For Quarter Ended Dec. 31, 2020 Were $1.6 Mln, Compared To $0.2 Mln For Same Period In 2019
Brief: Codiak Announces Pricing Of $57.8 Mln Public Offering Of Common Stock
Brief: Codiak Announces Proposed Public Offering Of Common Stock
Brief: Codiak Reports Additional Positive Phase 1 Results For ExoIL-12
U.S. RESEARCH ROUNDUP- Caterpillar, Palo Alto Networks, Stryker
Brief: Codiak Reports Positive Initial Phase 1 Results For exoIL-12 In Healthy Volunteers
U.S. STOCKS ON THE MOVE-J&J, Mogo, BridgeBio Pharma, Sandridge Energy
U.S. STOCKS ON THE MOVE-CSX Corp, Square, Delta Air, Suncor, BlackBerry
Brief: Codiak Biosciences Reports Third Quarter 2020 Financial Results And Operational Progress
U.S. RESEARCH ROUNDUP-Mattel, Obseva, Technipfmc